You are here

  • Home
  • Archive
  • Volume 11, Issue Suppl 1
  • 468 Characteristics of toripalimab: a next generation anti-PD-1 antibody with potent T cell activation and enhanced clinical efficacy irrespective of PD-L-1 status

Article metrics

Article menu

Download PDFPDF

Regular and Young Investigator Award Abstracts
Checkpoint Blockade Therapy
468 Characteristics of toripalimab: a next generation anti-PD-1 antibody with potent T cell activation and enhanced clinical efficacy irrespective of PD-L-1 status

 

Online download statistics by month:

Online download statistics by month: November 2023 to August 2024

AbstractFullPdf
Nov 2023390031
Dec 2023289017
Jan 202412007
Feb 202417409
Mar 2024266018
Apr 2024182024
May 202415708
Jun 2024133015
Jul 2024148018
Aug 2024188010
Total20470157